Therapeutic areas

24 therapeutic areas · 22 with coverage

• Anesthesiology

  Anaesthetic agents, delivery systems and the monitoring that surrounds them.

  1 story on this site

  • MHRA Flags Ventilator Failure Risk in Dräger Atlan Units

• Cardiovascular

  Heart and vascular products — valves, rhythm devices, heart failure and hypertension.

  17 stories on this site

  • HighLife Raises $90M for US Valve Trial, EU Growth
  • FDA Approves Cordis' Sirolimus-Eluting Balloon
  • Traferox Lands FDA Clearance for X°Port Heart System
  • Powerful Medical Wins First FDA Nod for AI-ECG Tool
  • FDA Expands WINREVAIR Label With HYPERION Data
  • MHRA Curbs Wireless Fetal Monitor Signal Mix-Ups
  • Emboline Clears FDA Hurdle for TAVR Debris Filter
  • FDA Breakthrough Status for Remote Robotic Stroke Device
  • and 9 more, in the archive

• Critical Care

  Intensive-care products: ventilation, haemodynamic support and sepsis management.

  6 stories on this site

  • Matisse Raises €14M for Phase 2 Sepsis Drug Trial
  • FDA Grants Nutromics' Patch Breakthrough Status
  • FDA Clarifies Path for Spectral's Sepsis Device
  • FDA Clears Masimo's Root With LiDCO for Oxygen Delivery
  • MHRA Flags Ventilator Failure Risk in Dräger Atlan Units
  • FDA Classifies Ventilator, Heart-Pump Recalls as Class I

• Dentistry & Oral Health

  Dental devices and oral-health products, including implants and restorative materials.

  No coverage yet — we track it, and will report it when it moves.

• Dermatology

  Skin disease and aesthetic products, including topical and photodynamic therapies.

  3 stories on this site

  • FDA Clears First Skin-Cancer Photodynamic Therapy
  • FDA Finalizes Adhesion Rules for Generic Skin Patches
  • FDA Retires a 1995 Guidance on Topical Steroids

• Endocrinology & Metabolic Disorders

  Diabetes, obesity and endocrine products, including the GLP-1 class and its supply.

  7 stories on this site

  • FDA Hits Empower Pharmacy With Fifth Warning Letter
  • Sling Nets $123M to Push Eye Drug Into Phase 3
  • TGA: Counterfeit Retatrutide Hid 8x-Dose Semaglutide
  • Beta Bionics Wins FDA Clearance for Mint Patch Pump
  • FDA Clears Abbott's Libre Duo Glucose-Ketone Monitor
  • UK First in Europe to Approve Lilly's Foundayo Pill
  • FDA Picks Dexcom as First TEMPO Pilot Participant

• Gastroenterology

  Digestive disease products, from IBD biologics to endoscopy systems.

  6 stories on this site

  • CHMP Recommends Zealand's Zeydovio for Bowel Disease
  • TriSalus Wins FDA Clearance for TriNav Advance
  • FDA Clears Neptune Medical's Robotic Endoscope
  • TGA: Counterfeit Retatrutide Hid 8x-Dose Semaglutide
  • MHRA Warns Against Infant Gas-Relief Catheters
  • MHRA's ILAP Passports Go to Liver Cancer, Dementia Drugs

• General Surgery

  Surgical instruments, energy devices and staplers, and their recalls.

  1 story on this site

  • FDA Breakthrough Status for Remote Robotic Stroke Device

• Infectious Diseases

  Antimicrobials, antivirals, vaccines and outbreak response, including emergency pathways.

  7 stories on this site

  • FDA Grants Second Breakthrough Nod to UTI Test Panel
  • Armata Wins Breakthrough Status for Phage Therapy AP-SA02
  • FDA Approves Fall 2026 COVID Shots, Keeps Narrow Use
  • MHRA Clarifies UK Path for Microbiome Medicines
  • FDA Approves First mRNA Flu Vaccine, Moderna's mFLUSIVA
  • FDA Gives Home COVID Tests a Permanent Class II Address
  • CHMP Backs the EU's First Refillable Eye Implant

• Minimally Invasive Surgery

  Laparoscopic, endovascular and catheter-based intervention, and the robotics behind it.

  9 stories on this site

  • HighLife Raises $90M for US Valve Trial, EU Growth
  • TriSalus Wins FDA Clearance for TriNav Advance
  • FDA Clears Neptune Medical's Robotic Endoscope
  • FDA Clears First Robotic LigaSure Vessel Sealer
  • Emboline Clears FDA Hurdle for TAVR Debris Filter
  • FDA Breakthrough Status for Remote Robotic Stroke Device
  • FDA Clears Spineart's Robotic Spine Screw App
  • MHRA Warns Against Infant Gas-Relief Catheters
  • and 1 more, in the archive

• Nephrology & Renal Care

  Kidney disease, dialysis and renal-replacement products.

  2 stories on this site

  • Dialybrid Raises €15M, Implants First Vascular Graft
  • FDA Approves MannKind's 10-Second Heart-Failure Autoinjector

• Neurology

  Neurological and neuromuscular products, from epilepsy to neurodegeneration and neurostimulation.

  7 stories on this site

  • SK Biopharmaceuticals Completes Japan Epilepsy Approval
  • CHMP Backs AstraZeneca's Klygefa for Rare Disorder
  • FDA Approves First Drug for Ataxia in Rare A-T
  • CorTec Lands Second FDA Breakthrough Nod for BCI
  • FDA Approves Telix's Pixclara for Glioma Imaging
  • FDA Approves Takeda's Orzeyful for Narcolepsy Type 1
  • MHRA's ILAP Passports Go to Liver Cancer, Dementia Drugs

• Oncology

  Cancer medicines and devices — approvals, accelerated pathways and advisory committees.

  24 stories on this site

  • Curium Wins FDA Approval for First Radioligand Rival
  • CHMP Clears First mAb Biosimilar Under New EU Path
  • Circle Pharma Raises $92.5M Series E for Cancer Drug
  • FDA Grants Fast Track to PureTech's MDS Antibody
  • CHMP Backs Corcept's Lifyorli for Ovarian Cancer
  • FDA Approves Lilly's Inluriyo-Verzenio Combo
  • FDA Updates IBTROZI Label With 4-Year Response Data
  • FDA Clears First Skin-Cancer Photodynamic Therapy
  • and 16 more, in the archive

• Ophthalmology

  Ocular medicines and devices — retina, glaucoma and intraocular products.

  2 stories on this site

  • FDA Clears Sight Sciences' OMNI Ultra for Glaucoma
  • CHMP Backs the EU's First Refillable Eye Implant

• Orthopedics

  Joint replacement, trauma fixation and spinal implants, and their wear and revision data.

  5 stories on this site

  • Cyllene Wins FDA RMAT Status for Bladder Gene Therapy
  • Shoulder Innovations Clears FDA Hurdle for N-22 Implant
  • Scholar Rock Wins FDA Nod for First SMA Muscle Drug
  • MHRA Flags Wear Risk in Five Modular-Neck Hip Implants
  • FDA Clears Spineart's Robotic Spine Screw App

• Otolaryngology (ENT)

  Ear, nose and throat products, including hearing and airway devices.

  3 stories on this site

  • FDA Hears Fight Over Who Can Give Psychedelic Therapy
  • FDA Grants Hearing on Generic Concerta After Decade
  • FDA Sets a September Hearing on Psychedelic Therapy

• Pain Management

  Analgesics and neuromodulation, and the controlled-substance questions around them.

  2 stories on this site

  • FemPulse Earns CE Mark for Wearable Bladder Ring
  • FDA Clears BlueWind's Revi Extend Bladder Implant

• Pediatrics

  Paediatric indications, study plans and the device sizes children actually need.

  3 stories on this site

  • FDA Approves First Gene Therapy for Sanfilippo Type A
  • Pharming Wins FDA Nod to Extend Joenja to Kids
  • MHRA Warns Against Infant Gas-Relief Catheters

• Rare Diseases

  Orphan designations, small populations and the evidence standards that come with them.

  4 stories on this site

  • FDA Approves First Drug for Ataxia in Rare A-T
  • FDA Approves First Gene Therapy for Sanfilippo Type A
  • FDA's CDRH Launches Rare Disease Device Initiative
  • CHMP Rejects Arimoclomol Again; Zevra Seeks Re-Examination

• Rehabilitation Medicine

  Rehabilitation and assistive technology, including prosthetics and mobility devices.

  1 story on this site

  • CorTec Lands Second FDA Breakthrough Nod for BCI

• Respiratory

  Respiratory medicines and devices — inhalers, ventilation and pulmonary disease.

  5 stories on this site

  • FDA Expands WINREVAIR Label With HYPERION Data
  • EU Approves GSK's Twice-Yearly Asthma Drug Exdensur
  • FDA Clears Tempus's AI Tool for Pulmonary Hypertension
  • FDA Debars Research Site Owners Who Faked Trial Data
  • MHRA Approves the World's First Low-Carbon Asthma Inhaler

• Urology

  Urological products, from bladder therapies to stone and continence devices.

  5 stories on this site

  • FDA Grants Second Breakthrough Nod to UTI Test Panel
  • Cyllene Wins FDA RMAT Status for Bladder Gene Therapy
  • FemPulse Earns CE Mark for Wearable Bladder Ring
  • FDA Clears First Robotic LigaSure Vessel Sealer
  • FDA Clears BlueWind's Revi Extend Bladder Implant

• Women’s Health

  Contraception, maternal and gynaecological care, and the safety communications around them.

  1 story on this site

  • France Warns 1.6 Million Women on Pill Meningioma Risk

• Wound Care

  Wound dressings, grafts and negative-pressure therapy.

  No coverage yet — we track it, and will report it when it moves.